Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Novel orally active antithrombotic agent from Fuji Yakuhin

March 27, 1997

Biological role of CD39 uncovered by Immunex and collaborators

March 26, 1997

Biogen licenses Hirulog

March 26, 1997

Cor Therapeutics receives nonapprovable letter for Integrilin NDA

March 26, 1997

CPMP approves lepirudin

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

Promising phase II data presented for Novastan in acute MI

March 21, 1997

Fujisawa presents selective, nonpeptide thrombin receptor inhibitor

March 21, 1997

Fujisawa selects orally active fibrinogen antagonist for clinical studies

March 20, 1997

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...